Abstract
Background
This study aimed to retrospectively evaluate the feasibility of total-body 18F-FDG PET/CT ultrafast acquisition combined with a deep learning (DL) image filter in the diagnosis of colorectal cancers (CRCs).
Methods
The clinical and preoperative imaging data of patients with CRCs were collected. All patients underwent a 300-s list-mode total-body 18F-FDG PET/CT scan. The dataset was divided into groups with acquisition durations of 10, 20, 30, 60, and 120 s. PET images were reconstructed using ordered subset expectation maximisation, and post-processing filters, including a Gaussian smoothing filter with 3 mm full width at half maximum (3 mm FWHM) and a DL image filter. The effects of the Gaussian and DL image filters on image quality, detection rate, and uptake value of primary and liver metastases of CRCs at different acquisition durations were compared using a 5-point Likert scale and semi-quantitative analysis, with the 300-s image with a Gaussian filter as the standard.
Results
All 34 recruited patients with CRCs had single colorectal lesions, and the diagnosis was verified pathologically. Of the total patients, 11 had liver metastases, and 113 liver metastases were detected. The 10-s dataset could not be evaluated due to high noise, regardless of whether it was filtered by Gaussian or DL image filters. The signal-to-noise ratio (SNR) of the liver and mediastinal blood pool in the images acquired for 10, 20, 30, and 60 s with a Gaussian filter was lower than that of the 300-s images (P < 0.01). The DL filter significantly improved the SNR and visual image quality score compared to the Gaussian filter (P < 0.01). There was no statistical difference in the SNR of the liver and mediastinal blood pool, SUVmax and TBR of CRCs and liver metastases, and the number of detectable liver metastases between the 20- and 30-s DL image filter and 300-s images with the Gaussian filter (P > 0.05).
Conclusions
The DL filter can significantly improve the image quality of total-body 18F-FDG PET/CT ultrafast acquisition. Deep learning-based image filtering methods can significantly reduce the noise of ultrafast acquisition, making them suitable for clinical diagnosis possible.
Supplementary Information
The online version contains supplementary material available at 10.1186/s13550-023-01015-z.
Keywords: Total-body PET/CT, Colorectal cancer, Fast acquisition, Diagnostic performance
Background
Recently, new PET/CT scanners with long-axial field of view (LAFOV) and silicon photomultiplier (SiPM) detection systems have been introduced, such as the axial FOV of 194-cm PET/CT (uEXPLORER, United Imaging Healthcare Co), 106-cm PET/CT (Biograph Vision Quadra, Siemens Healthineers), and 64-cm PET/CT (PennPET Explorer) scanners [1–4]. These LAFOV PET/CT scanners are characterised by increased sensitivity owing to their ability to collect more photons during scanning, allowing reduced tracer injection doses and shortened acquisition time.
Shorter acquisition durations are desirable for the comfort of patients, particularly those who are distressed, claustrophobic, have shortness of breath, are children, or require less dosage of anaesthetic; shorter acquisition durations is also cost-effective. One of the challenges in routine PET/CT is to deal with patients with dyspnoea in a recumbent position or severe pain following bone metastases. In such cases, maintaining diagnostic performance whilst achieving fast PET acquisitions would be especially beneficial.
However, shortening the acquisition time may result in increased noise, lower signal-to-noise ratio (SNR), and potentially unnecessary image artefacts [5]. These factors may affect the quality and accuracy of the images, potentially compromising the diagnosis and treatment planning for the patient, especially for the detection of liver metastases or interference of physiological accumulation of 18F-FDG by the adjacent colon in colorectal cancer (CRC). Benign FDG uptake in the colon on PET/CT indicates physiological uptake, inflammation (such as inflammatory bowel disease), and benign lesions (such as benign polyps). This can affect the detection and diagnosis of CRCs, especially when the difference between tumour and colon benign uptake is not significant or when there is noise interference.
The advent of deep learning-based image filters has the potential to decrease noise and enhance image quality in short-term image acquisition, such as HYPER DLR launched by United Imaging Healthcare and licenced by the US Food and Drug Administration (FDA) 510(k) clearance. HYPER DLR, a deep learning-based algorithm for PET image filters, can effectively remove noise from images captured under low count rate conditions, significantly improving image quality. This technology can boost image SNRs by 42% and increase imaging speed [6].
Xing et al. attempted to use HYPER DLR to reduce image noise and achieved good results, but did not evaluate the image quality with an acquisition time of less than 1 min [6]. Some researchers have explored ultrafast PET acquisition and attempted to evaluate PET image quality within 1 min [7–10]. However, image noise caused by short-term acquisition using a Gaussian filter has affected the diagnosis, with standard detectors covering an axial field of view [11]. Although these studies on the ultrafast acquisition of PET/CT have revealed that acquisition speed has significantly improved, studies on the quality of images using a Gaussian filter still need to be completed. Further to this, previous studies have included a variety of diseases, but there is a lack of research on CRC, specifically in patients with liver metastasis. The effect of liver noise on the ability to detect metastatic tumours remains unknown.
Therefore, considering the 300-s OSEM reconstruction image with a 3 mm Gaussian smoothing filter as a standard image, we retrospectively compared the effects of the Gaussian and DL image filters on image quality, detection rate, and uptake rate of primary and metastatic CRCs in total-body PET/CT imaging at different acquisition durations (10, 20, 30, 60, and 120 s).
Methods
Study design and population
The local Institutional Review Board approved this retrospective study (No. KY2023-020-01) and waived the requirement for informed consent. From April 2022 to December 2022, 34 consecutive patients with CRCs were enrolled in this study.
Inclusion criteria
Patients were included in this study based on the following inclusion criteria: (i) no previous history of malignancies; (ii) the diagnosis was confirmed by histopathology; and (iii) only received symptomatic treatment and had no history of chemotherapy, radiotherapy, or surgical resection before the PET/CT scan.
Exclusion criteria
Patients were excluded for the following reasons: (i) incomplete image datasets and (ii) lack of a final histological diagnosis.
Patient preparation and PET/CT protocol
All patients fasted for more than 4 h before 18F-FDG injection according to the EANM procedure guidelines for tumour imaging (version 2.0) [12]. All patients underwent implantation of 22 G indwelling intravenous catheters (Jierui Medical Product), followed by 18F-FDG manual administration with 2.96 MBq/kg. The patients were instructed to lie on the bed as calmly as possible. Imaging was started 60 ± 5 min after 18F-FDG injection. Image acquisition was performed using a total-body PET/CT scanner (uEXPLORER, United Imaging Healthcare, Shanghai, China) with an axial FOV of 194 cm. Additional file 1: Table 1 lists the parameters of the PET component of the PET/CT scanner. Low-dose CT was performed before PET for attenuation correction and anatomical localisation with a dose-modulation technique. Subsequently, total-body PET imaging was performed using a 3D list-mode with 300-s acquisition for one-bed position.
PET images were initially reconstructed with OSEM using data from the full 300-s acquisition. Images were post-processed using a 3 mm isotropic Gaussian smoothing filter. The necessary correction methods were applied, such as attenuation and scatter correction. Subsequently, the PET images were reconstructed using various acquisition times (10, 20, 30, 60, and 120 s) to simulate fast scans with both Gaussian and DL image filters. The parameters used in the OSEM reconstruction process included time of flight (TOF) and point spread function (PSF) modelling, three iterations, 20 subsets, 600 cm field of view, a matrix size of 192 × 192, a pixel size of 3.125 × 3.125 × 2.886 mm3, and a Gaussian post-filter of 3 mm FWHM. For the DL image filter process, the Gaussian post-filter was replaced, whereas all other reconstruction parameters were the same as described above.
Imaging analysis
All images were transferred to a workstation (uWS-MI:R002, United Imaging Healthcare) and reviewed in standard planes. Taking the 300-s image with a Gaussian filter image as a standard image, Gaussian and DL filtering images with five image datasets (10, 20, 30, 60, and 120 s) were included for comparison.
For qualitative analysis, the image quality of various time-point PET/CT datasets was evaluated visually by two nuclear physicians (Xiaochun Zhang and Taotao Sun) with over a decade of experience in PET/CT diagnosis. According to the widely used 5-point Likert scale, the image quality was scored, and the criteria were as follows: (i) very poor image quality and excessive noise (score 1); (ii) poor image quality and increased noise (score 2); (iii) fair image quality, similar to the regular image of daily practice (score 3); (iv) good image quality, superior to the regular image of daily practice (score 4); and (v) excellent image quality with minimal noise (score 5) [13–17]. The two readers were blinded to the evaluation of the various time-point PET/CT dataset images and scored.
To eliminate intra-observer variability in the quantitative analysis, PET/CT images were quantitatively evaluated by a single nuclear physician with over a decade of experience in PET/CT diagnosis. Semi-automatic 3D delineation of the FDG-avid lesions was performed to cover the entire tumour. 3D isocontour volume of interest (VOI) based on 41% of the maximum standardised uptake value (SUVmax) thresholds was used and recommended by EANM guidelines [12]. The tumour VOIs were obtained with the 300-s OSEM reconstruction with Gaussian (3 mm FWHM) filter and subsequently replicated and applied to other PET acquisition datasets of images. Mean standardised uptake value (SUVmean), maximum standardised uptake value (SUVmax), and peak standardised uptake value (SUVpeak) within a 1-cm3 spherical volume were automatically generated.
According to the recommendations of PERCIST, hepatic 18F-FDG activity was assessed using a fixed 3-cm-diameter spherical VOI on the right lobe of the liver [18, 19]. Additionally, 18F-FDG activity in the mediastinal blood pool was evaluated using a cylindrical VOI with a diameter of 1 cm and a long axis of 2 cm (parallel to the descending aorta) at the centre of the descending thoracic aorta. The SUVmean and standard deviation (SD) of the liver and mediastinal blood pool were recorded. The liver and mediastinal blood pool SNRs were calculated by dividing SUVmean by SD. The calculation formula used was as follows:
The tumour-to-background ratio (TBR) was calculated by dividing the SUVmax of the tumour by the SUVmean of the liver. The calculation formula used was as follows:
To evaluate the detectability of the primary lesion of CRCs, the SUVmax of the adjacent proximal and distal bowel of the tumour was measured, and the tumour-to-adjacent bowel ratio (TAR) was calculated. The calculation formula used was as follows:
For patients with multiple liver metastases, the number of liver metastases was found on the 300-s image with a Gaussian filter image as a standard image reference, and the analysis focused on the largest and smallest lesions on the standard reconstruction. The liver metastases TBR and detection rate of liver metastases were calculated. The calculation formula used was as follows:
Statistical analysis
Continuous variables were presented as mean ± SD, and categorical variables were presented as frequencies and percentages. The weighted Kappa statistic was applied to evaluate inter-observer agreement for different acquisition durations of the PET/CT datasets image scores. The value of the agreement was categorised as follows: no agreement (κ < 0), slight agreement (0 ≤ κ < 0.2), fair agreement (0.21 ≤ κ < 0.4), moderate agreement (0.41 ≤ κ < 0.6), substantial agreement (0.61 ≤ κ < 0.8), and excellent agreement (0.81 ≤ κ ≤ 1). The Friedman’s test with post hoc comparisons using Bonferroni correction was used to compare differences in SNR, TBR, and tumour SUVs among various time-point PET/CT dataset images. Statistical analyses were performed using SPSS (v.26.0), GraphPad Prism (v.9.0.0), and MedCalc (v.19.0.7). A two-tailed probability value of < 0.05 was considered statistically significant.
Results
Population
From April 2022 to December 2022, 34 consecutive patients with a single CRC lesion, histopathologically confirmed, were enrolled in this study. Of the total patients, 11 had liver metastases, and 113 liver metastases were detected. All 11 patients underwent triple-phase abdominal contrast-enhanced CT (CECT), and the size of the liver metastases was measured using enhanced CT. Patient characteristics are shown in Table 1. The distribution of the primary tumour sites in CRCs is shown in Additional file 2: Fig. 1.
Table 1.
Characteristics | Value |
---|---|
Number of patients | 34 |
Age (years) | 67 (32–93) |
Gender, n (%) | |
Male | 20 |
Female | 14 |
Weight (kg) | 56.9 ± 12.0 (35.0–85.0) |
Height (cm) | 161.4 ± 8.5 (143.0–181.0) |
BMI (kg/m2) | 21.7 ± 3.4 (15.6–30.1) |
Fasting blood glucose level (mg/dl) | 105.4 ± 18.8 (73.8–160.2) |
18F-FDG injection dose (MBq) | 168.4 ± 35.5 (103.6–251.6) |
CEA (ng/ml) | 74.5 ± 185.3 (0.92–1033.0) |
Delay time (min) | 60 ± 4.3 (51–72) |
Location (number of patients) | |
Rectal cancer | 1 |
Colon cancer | 33 |
Ascending | 11 |
Transverse | 5 |
Descending | 10 |
Sigmoid | 7 |
TNM | |
I-II | 6 |
III | 11 |
IV | 17 |
Primary tumour | |
SUVmax | 21.6 ± 13.9 (7.3–82.7) |
TBR | 8.8 ± 4.9 (2.9–26.7) |
Liver metastases | |
SUVmax | 8.4 ± 5.2 (3.2–22.7) |
TBR | 3.7 ± 2.2 (1.5–8.4) |
Size | |
Largest lesion | 4.6 ± 2.7 (1.0–8.5) |
Minimal lesion | 0.9 ± 0.4 (0.6–2.1) |
Qualitative assessment of image quality and inter-observer agreement
Based on a 5-point Likert scale, the weighted kappa coefficient for the inter-observer agreement of the image quality evaluation was 0.822 (95% confidence interval, 0.655–0.989). The 10-, 20-, and 30-s acquisition durations images with Gaussian filter were scored 1 or 2, and none were scored 3. DL image filter significantly improved the visual image quality scores of 20-, 30-, and 60-s acquisition time images compared to Gaussian filter (P < 0.01) (Additional file 3: Fig. 2 and Additional file 4: Fig. 3). The scores of PET image using Gaussian and DL image filter for different acquisition durations are shown in Fig. 1.
Quantitative assessment of image quality
The 10-s dataset could not be evaluated due to high noise, regardless of whether it was filtered by Gaussian or DL image filters. The SNR of the liver and mediastinal blood pool in the images acquired for 10, 20, 30, and 60 s with a Gaussian filter was lower than that of the 300-s images (P < 0.01) (Additional file 5: Fig. 4). The DL filter significantly improved the SNR and visual image quality score compared to the Gaussian filter (P < 0.01). There was no statistical difference in the SNR of the liver (P = 0.176 and P = 0.635) and mediastinal blood pool (P = 0.257 and P = 0.942) between the 20- and 30-s DL image filter and 300-s images with the Gaussian filter. The SNR of different acquisition duration images with Gaussian and DL image filters is shown in Fig. 2, Table 2, and Table 3.
Table 2.
Parameter | Gaussian filter | Deep learning filter | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
10S | 20S | 30S | 60S | 120S | 300S | 10S | 20S | 30S | 60S | 120S | |
SNR | |||||||||||
Liver | 3.3 ± 0.7 | 4.6 ± 1.0 | 5.6 ± 1.2 | 8 ± 1.9 | 11.1 ± 3.3 | 17.0 ± 4.4 | 8.4 ± 4.0 | 14.7 ± 6.2 | 18.7 ± 6.7 | 26.4 ± 8.1 | 32.8 ± 9.2 |
Aorta | 3.7 ± 0.9 | 5.1 ± 1.2 | 6.2 ± 1.5 | 8.6 ± 2.2 | 11.9 ± 3.7 | 18.8 ± 6.9 | 11.0 ± 5.2 | 16.7 ± 6.9 | 19.4 ± 7.3 | 24.6 ± 7.5 | 30.5 ± 12.5 |
SUVmax | |||||||||||
Lesion of CRCs | 26.1 ± 14.8 | 24.0 ± 14.0 | 23.4 ± 13.9 | 22.8 ± 14.5 | 22.3 ± 14.8 | 21.6 ± 13.9 | 21.7 ± 13.4 | 20.4 ± 13.1 | 19.9 ± 12.9 | 19.5 ± 13.3 | 19.1 ± 13.4 |
Liver metastases | 10.3 ± 6.0 | 9.6 ± 5.9 | 9.4 ± 5.8 | 8.8 ± 5.3 | 8.5 ± 5.1 | 8.4 ± 5.2 | 8.3 ± 5.2 | 7.8 ± 5.2 | 7.6 ± 5.0 | 7.3 ± 4.9 | 7.2 ± 4.9 |
TBR | |||||||||||
Lesion of CRCs | 10.5 ± 5.3 | 9.7 ± 5.0 | 9.4 ± 4.9 | 9.2 ± 5.1 | 9.0 ± 5.2 | 8.8 ± 4.9 | 8.7 ± 4.5 | 8.2 ± 4.6 | 8.1 ± 4.5 | 7.9 ± 4.6 | 7.8 ± 4.7 |
Liver metastases | 4.5 ± 2.7 | 4.2 ± 2.6 | 3.9 ± 2.3 | 3.8 ± 2.3 | 3.7 ± 2.2 | 3.7 ± 2.2 | 3.6 ± 2.3 | 3.9 ± 2.2 | 3.3 ± 2.2 | 3.2 ± 2.1 | 3.2 ± 2.1 |
TAR | 6.5 ± 4.1 | 6.9 ± 4.4 | 6.9 ± 4.2 | 7.1 ± 4.1 | 7.1 ± 4.2 | 7.5 ± 4.4 | 7.4 ± 4.9 | 7.5 ± 5.0 | 7.4 ± 5.0 | 7.2 ± 4.7 | 7.1 ± 4.6 |
Table 3.
Gaussian filter | Deep learning filter | P value | ||
---|---|---|---|---|
300S | 20S | 30S | ||
SNR | ||||
Liver | 17.0 ± 4.4 | 14.7 ± 6.2 | 18.7 ± 6.7 | P > 0.05 |
Aorta | 18.8 ± 6.9 | 16.7 ± 6.9 | 19.4 ± 7.3 | P > 0.05 |
SUVmax | ||||
Lesion of CRCs | 21.6 ± 13.9 | 20.4 ± 13.1 | 19.9 ± 12.9 | P > 0.05 |
Liver metastases | 8.4 ± 5.2 | 7.8 ± 5.2 | 7.6 ± 5.0 | P > 0.05 |
TBR | ||||
Lesion of CRCs | 8.8 ± 4.9 | 8.2 ± 4.6 | 8.1 ± 4.5 | P > 0.05 |
Liver metastases | 3.7 ± 2.2 | 3.9 ± 2.2 | 3.3 ± 2.2 | |
TAR | 7.5 ± 4.4 | 7.5 ± 5.0 | 7.4 ± 5.0 | P > 0.05 |
Quantitative assessment of colorectal cancer and liver metastases
The SUVmax and TBR of CRCs and liver metastases gradual increased with decreasing acquisition times. There were no statistical differences in the SUVmax (P = 0.961 and P = 0.071) and TBR (P = 0.189 and P = 0.081) of CRCs and liver metastases between the 20- and 30-s DL image filter and 300-s images with the Gaussian filter. The SUVmax and TBR of different acquisition durations of images with Gaussian and DL image filters are shown in Fig. 3, Tables 2, and Table 3. The SUVmax and TBR of the 60- and 120-s images with DL image filter were lower than those of the 300-s images with Gaussian filter (P < 0.01) (Additional file 6: Fig. 5). A comparison of all quantitative data is presented in Additional file 7: Table 2.
To evaluate the detectability of primary lesions of CRCs, we introduced TAR, which is the ratio of the primary tumour to tumour–adjacent bowel SUVmax. There was no statistical difference in the TAR (P = 0.324, P = 0.306, P = 0.125, and P = 0.073) between the Gaussian and DL image filter images with different acquisition durations (20, 30, 60, and 120 s) and the 300-s images with Gaussian filter image.
With the 300-s images with Gaussian filter image as a standard image reference, a total of 113 liver metastases were detected. The 10- and 20-s acquisition durations images with Gaussian filter exhibited noticeable noise, making it difficult to observe small liver metastases (Fig. 4). Sub-centimetre liver metastases were not conducive to display on the DL image filter image (Fig. 5). Compared with the 300-s images with Gaussian filter images, the detection rate of liver metastases on 60 and 120-s images with DL image filter decreased. In terms of the number of detectable liver metastases, the 10- and 20-s acquisition durations images with Gaussian filter were significantly lower than the 300-s images with Gaussian filter images (P < 0.05). There was no statistical difference in the number of detectable liver metastases between the 20- and 30-s images with DL filter and the 300-s images with Gaussian filter image (P = 0.077 and P = 0.123).
Discussion
Our current study shows that DL image filter can significantly improve the image quality and SNR for low count data. Without affecting the quantitative evaluation of CRCs or liver metastases, the acquisition time of total-body PET/CT can be reduced to 20 s using DL image filter. For the visual qualitative evaluation of image quality, DL image filter significantly improved the image quality score of 20-, 30-, and 60-s acquisition time images compared with Gaussian filter (P < 0.01). Visually, there was no difference in image quality between DL image filter images and 300-s images with Gaussian filter images (Additional file 8: Fig. 6). For the SNR of the liver and mediastinal blood pool, compared with Gaussian filter, DL image filter can increase the SNR of 20-s, 30-s, and 60-s datasets images by three times (Fig. 3A and 3B). Because of the 10-s datasets, whether Gaussian filter or DL image filter was too poor in SNR, it was not considered. Compared with the 300-s images with Gaussian filter images, the SNR of the 20- and 30-s images with DL image filter was similar.
When the acquisition time for PET/CT imaging is reduced, the image noise level tends to increase significantly. The SUVmax of CRC and liver metastatic lesions also tends to increase gradually. This observation applies to both images processed with a Gaussian filter and DL image filter. However, it is noted that the increase in SUVmax is relatively lower when using the DL image filter compared to the Gaussian filter. The detection of sub-centimetre liver metastases of CRCs is still a problem that puzzles PET/CT daily work. It is worth noting that DL image filter makes it difficult to detect sub-centimetre liver metastases from CRCs.
In this study, we compared the data from similar studies [9]. The results are presented in Table 4. Compared with the current study, the SNR of the liver and mediastinal blood pool in Zhang et al.’s study is higher than that of our image data, whether it is 30- or 300-s image with a Gaussian filter. We speculate that this is caused by different FDG doses (3.7 vs. 2.96 MBq/kg).
Table 4.
Gaussian filter | P value | Gaussian filter | Deep learning filter | P value | ||||
---|---|---|---|---|---|---|---|---|
300S | 30S | 300S | 30S | 20S | ||||
The current study | SNR | |||||||
Liver | 17.0 ± 4.4 | 5.6 ± 1.2 | P < 0.01 | 17.0 ± 4.4 | 18.7 ± 6.7 | 14.7 ± 6.2 | P > 0.05 | |
Aorta | 18.8 ± 6.9 | 6.2 ± 1.5 | P < 0.01 | 18.8 ± 6.9 | 19.4 ± 7.3 | 16.7 ± 6.9 | P > 0.05 | |
SUVmax | 21.6 ± 13.9 | 23.4 ± 13.9 | 0.063 | 21.6 ± 13.9 | 19.9 ± 12.9 | 20.4 ± 13.1 | P > 0.05 | |
TBR | 8.8 ± 4.9 | 9.4 ± 4.9 | 0.418 | 8.8 ± 4.9 | 8.1 ± 4.5 | 8.2 ± 4.6 | P > 0.05 | |
Zhang et al | SNR | |||||||
Liver | 19.71 ± 5.58 | 9.03 ± 2.51 | P < 0.01 | |||||
Aorta | 16.60 ± 6.48 | 10.43 ± 3.1 | P < 0.01 | |||||
SUVmax | 13.94 ± 11.83 | 15.48 ± 14.19 | 0.003 | |||||
TBR | 4.43 ± 3.61 | 4.54 ± 3.80 | 0.411 |
Meanwhile, we also found that the SNR of the 20- and 30-s DL image filter images was higher than that of Zhang et al.’s 30-s Gaussian filter image [9]. Additionally, the SNR of 30-s DL image filter image was similar to that of Zhang et al.’s 300 s with a Gaussian filter image [9]. It has been demonstrated that the SNR of DL image filter images is better than that of Gaussian filter by a 30-s ultrafast acquisition by total-body PET/CT. And the 30-s DL image filter images was equivalent to the 300-s reconstruction images. The SUV and TBR of CRCs in this study were significantly higher than those in Zhang et al.’s study, presumably because of the different types of tumours included.
The increase in image noise due to fast acquisition may affect the detection and diagnosis of CRCs, especially when the difference between tumour and benign colon uptake is not significant or noise interference. Our study also evaluated the detectability of CRC lesions, compared the difference between CRC lesions and adjacent bowel benign FDG uptake, and used the SUVmax of lesions and adjacent bowel uptake. The shortened acquisition time led to deviations in SUVmax caused by noise.
Significantly, compared with the 300-s image with a Gaussian filter images, we have shortened the acquisition time and are more friendly to patients who cannot tolerate the conventional PET/CT acquisition time. In the routine management of CRCs, ultrafast acquisition may be a practical substitute for 300-s PET/CT acquisition.
Additionally, our study found that the SUVmax of the Gaussian filter image datasets acquired for more than 60 s was consistent with the results of the datasets acquired for 5 min (Fig. 4). Our results are consistent with Tan et al.’s research on assessing CRCs with data collected at 1–5 different minute time points using the same equipment [20]. However, these results differ from those of Sher et al., who found that the SUVmax of images collected at 1.5 min differed from those collected at 5 min [21]. This may be due to differences in equipment (long-axial FOV PET detectors and standard PET detectors) and the composition of the study cases, which are not focused on CRCs (mainly lymphoma and lung cancer).
Limitations of our study
The limitations of this study include its small sample size and retrospective design. One limitation of this study is that only one patient had a BMI greater than 30, defined as obesity. It is well known that obesity affects SNR and reduces the SNR of fast-acquisition PET images. This study also did not qualitatively and quantitatively evaluate the nearby lymph nodes of colorectal cancer, which will be the focus of the next step.
Conclusions
The DL filter can significantly improve the image quality of total-body 18F-FDG PET/CT ultrafast acquisition. Deep learning-based image filtering methods can significantly reduce the noise of ultrafast acquisition, making them suitable for clinical diagnosis possible.
Supplementary Information
Acknowledgements
Not applicable.
Abbreviations
- CECT
Contrast-enhanced CT
- CRC
Colorectal cancer
- FOV
Field of view
- LAFOV
Long-axial field of view
- OSEM
Ordered subset expectation maximisation
- PSF
Point spread function
- SNR
Signal-to-noise ratio
- SiPM
Silicon photomultiplier
- SD
Standard deviation
- SUVmax
Standardised uptake value
- SUVmean
Mean standardised uptake value
- SUVpeak
Peak standardised uptake value
- TAR
Tumour-to-adjacent bowel ratio
- TBR
Tumour-to-background ratio
- TOF
Time of flight
Author contributions
ETL and ZJL contributed equally to this work. ETL, ZJL, LJ, and ZYL were involved in conception and design. LJ and ZYL contributed to administrative support. ZJL and YLY were involved in provision of study materials or patients. ETL, YLY, XCZ, and TTS contributed to collection and assembly of data. ETL, ZJL, and YLY were involved in data analysis and interpretation. YL and YMZ contributed to technical support of deep learning reconstruction, parameter adjustment, and optimisation. ETL, ZJL, and YLY were involved in manuscript writing. All authors contributed to final approval of manuscript.
Funding
This work was funded by Regional Innovation and Development Joint Fund of National Natural Science Foundation of China (No.U22A20345); Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application (No. 2022B1212010011); the National Key R&D Program of China (No. 2021YFF1201003); and the High-level Hospital Construction Project of Guangdong (No. DFJHBF202105).
Availability of data and materials
All data in the current study are available from the corresponding author on reasonable request.
Declarations
Ethics approval and consent to participate
The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Research Ethics Committee of Guangdong Provincial People’s Hospital (No. KY2023-020–01), and individual consent for this retrospective analysis was waived.
Consent for publication
Not applicable.
Competing interests
Author Yang Lv and Yumo Zhao are all full-time employees of United Imaging Healthcare, Shanghai, China. The other authors working at Guangdong Provincial People’s Hospital have full control of the data and declare that they have no conflict of interest. All authors have completed the ICMJE uniform disclosure form.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Entao Liu and Zejian Lyu contributed equally to this work.
Contributor Information
Lei Jiang, Email: jianglei6814@gdph.org.cn.
Zaiyi Liu, Email: liuzaiyi@gdph.org.cn.
References
- 1.Badawi RD, Shi H, Hu P, Chen S, Xu T, Price PM, et al. First human imaging studies with the EXPLORER total-body PET scanner. J Nucl Med. 2019;60:299–303. doi: 10.2967/jnumed.119.226498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pantel AR, Viswanath V, Daube-Witherspoon ME, Dubroff JG, Muehllehner G, Parma MJ, et al. PennPET explorer: human imaging on a whole-body imager. J Nucl Med. 2020;61:144–151. doi: 10.2967/jnumed.119.231845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nadig V, Herrmann K, Mottaghy FM, Schulz V. Hybrid total-body pet scanners-current status and future perspectives. Eur J Nucl Med Mol Imaging. 2022;49:445–459. doi: 10.1007/s00259-021-05536-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Alberts I, Hünermund J-N, Prenosil G, Mingels C, Bohn KP, Viscione M, et al. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the biograph vision Quadra with the biograph vision PET/CT. Eur J Nucl Med Mol Imaging. 2021;48:2395–2404. doi: 10.1007/s00259-021-05282-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Akamatsu G, Ishikawa K, Mitsumoto K, Taniguchi T, Ohya N, Baba S, et al. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters. J Nucl Med. 2012;53:1716–1722. doi: 10.2967/jnumed.112.103861. [DOI] [PubMed] [Google Scholar]
- 6.Xing Y, Qiao W, Wang T, Wang Y, Li C, Lv Y, et al. Deep learning-assisted PET imaging achieves fast scan/low-dose examination. EJNMMI Phys. 2022;9:7. doi: 10.1186/s40658-022-00431-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Lasnon C, Coudrais N, Houdu B, Nganoa C, Salomon T, Enilorac B, et al. How fast can we scan patients with modern (digital) PET/CT systems? Eur J Radiol. 2020;129:109144. doi: 10.1016/j.ejrad.2020.109144. [DOI] [PubMed] [Google Scholar]
- 8.Hu P, Zhang Y, Yu H, Chen S, Tan H, Qi C, et al. Total-body 18F-FDG PET/CT scan in oncology patients: How fast could it be? Eur J Nucl Med Mol Imaging. 2021;48:2384–2394. doi: 10.1007/s00259-021-05357-5. [DOI] [PubMed] [Google Scholar]
- 9.Zhang Y, Hu P, He Y, Yu H, Tan H, Liu G, et al. Ultrafast 30-s total-body PET/CT scan: a preliminary study. Eur J Nucl Med Mol Imaging. 2022;49:2504–2513. doi: 10.1007/s00259-022-05838-1. [DOI] [PubMed] [Google Scholar]
- 10.Balamoutoff N, Serrano B, Hugonnet F, Garnier N, Paulmier B, Faraggi M. Added value of a single fast 20-second deep-inspiration breath-hold acquisition in FDG PET/CT in the assessment of lung nodules. Radiology. 2018;286:260–270. doi: 10.1148/radiol.2017160534. [DOI] [PubMed] [Google Scholar]
- 11.Filippi L, Schillaci O. Total-body [18F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true? Eur J Nucl Med Mol Imaging. 2022;49:3322–3327. doi: 10.1007/s00259-022-05791-z. [DOI] [PubMed] [Google Scholar]
- 12.Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–354. doi: 10.1007/s00259-014-2961-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Everaert H, Vanhove C, Lahoutte T, Muylle K, Caveliers V, Bossuyt A, et al. Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera. Eur J Nucl Med Mol Imaging. 2003;30:1615–1619. doi: 10.1007/s00259-003-1317-8. [DOI] [PubMed] [Google Scholar]
- 14.Sjövall J, Bitzén U, Kjellén E, Nilsson P, Wahlberg P, Brun E. Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging. 2016;43:609–616. doi: 10.1007/s00259-015-3194-3. [DOI] [PubMed] [Google Scholar]
- 15.Sekine T, Delso G, Zeimpekis KG, de Galiza BF, ter Voert EEGW, Huellner M, et al. Reduction of 18F-FDG dose in clinical PET/MR imaging by using silicon photomultiplier detectors. Radiology. 2018;286:249–259. doi: 10.1148/radiol.2017162305. [DOI] [PubMed] [Google Scholar]
- 16.van Sluis J, Boellaard R, Somasundaram A, van Snick PH, Borra RJH, Dierckx RAJO, et al. Image quality and semiquantitative measurements on the biograph vision PET/CT system: initial experiences and comparison with the biograph mCT. J Nucl Med. 2020;61:129–135. doi: 10.2967/jnumed.119.227801. [DOI] [PubMed] [Google Scholar]
- 17.Chen W, Liu L, Li Y, Li S, Li Z, Zhang W, et al. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG. Eur J Nucl Med Mol Imaging. 2022;49:4145–4155. doi: 10.1007/s00259-022-05893-8. [DOI] [PubMed] [Google Scholar]
- 18.Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S–S150. doi: 10.2967/jnumed.108.057307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jh O, Lodge MA, Wahl RL. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology. 2016;280:576–84. doi: 10.1148/radiol.2016142043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Tan H, Cai D, Sui X, Qi C, Mao W, Zhang Y, et al. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience. Eur J Nucl Med Mol Imaging. 2022;49:1002–1011. doi: 10.1007/s00259-021-05537-3. [DOI] [PubMed] [Google Scholar]
- 21.Sher A, Lacoeuille F, Fosse P, Vervueren L, Cahouet-Vannier A, Dabli D, et al. For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time. EJNMMI Res. 2016;6:21. doi: 10.1186/s13550-016-0177-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data in the current study are available from the corresponding author on reasonable request.